C. Baker

A reply to ‘Efficacy and safety of widefield radiation therapy for extensive skin field cancerization remains unproven’

R. Sinclair, P. Foley, S. Shumack, 2024, JEADV Clinical Practice.

Efficacy and safety analysis: 24‐month outcomes from a prospective cohort of 106 fields treated with widefield radiation therapy for extensive skin field cancerization, with or without keratinocyte cancers

Andrew Potter, B. Wong, R. Sinclair, 2023, JEADV Clinical Practice.

The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR) – Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare drug eruptions

J. Trubiano, S. Ojaimi, J. S. Fok, 2024, The World Allergy Organization journal.